Curanex Pharmaceuticals Inc (CURX) stock
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.70+0.07 (+1.40%)
Close on Nov 17, 2026Market cap $7.37MP/E –Yield –
Curanex Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Curanex Pharmaceuticals's cash was $1.58M at Sep 30, 2026. For fiscal 2025 it was $4.97M, up 3240.1% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.97M | +3240.1% |
| FY2024 | Dec 31, 2024 | $148.89K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.58M | -72.8% |
| Q2 FY2026 | Jun 30, 2026 | $2.94M | +2599.3% |
| Q1 FY2026 | Mar 31, 2026 | $4.00M | +2586.5% |
| Q4 FY2025 | Dec 31, 2025 | $4.97M | – |
| Q3 FY2025 | Sep 30, 2025 | $5.80M | – |
| Q2 FY2025 | Jun 30, 2025 | $108.86K | – |
| Q4 FY2024 | Dec 31, 2024 | $148.89K | – |
See a number that looks wrong?